Katharine E Black Selected Research

4- (3- chloro- 2- fluorophenoxy)- 1- ((6- (1,3- thiazol- 2- ylamino)pyridin to 2-yl)methyl) cyclohexanecarboxylic acid

1/2022

Screening for Inhibitors of YAP Nuclear Localization Identifies Aurora Kinase A as a Modulator of Lung Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharine E Black Research Topics

Disease

11	Fibrosis (Cirrhosis) 01/2022 - 03/2009
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2016
4	Lung Injury 01/2021 - 03/2009
4	Inflammation (Inflammations) 05/2013 - 11/2008
2	Neoplasms (Cancer) 01/2022 - 01/2016
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 10/2011 - 03/2009
1	Critical Illness (Critically Ill) 12/2022
1	COVID-19 12/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Cicatrix (Scar) 01/2021
1	Bronchiectasis 01/2020
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Hypotension (Low Blood Pressure) 01/2018
1	Systemic Scleroderma (Systemic Sclerosis) 12/2016
1	Virus Diseases (Viral Diseases) 05/2013
1	Central Nervous System Infections (Central Nervous System Infection) 01/2007
1	Blastomycosis 01/2007
1	Histoplasmosis 01/2007
1	Infections 01/2007

Drug/Important Bio-Agent (IBA)

7	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 03/2009
3	Hyaluronic Acid (Hyaluronan)IBA 05/2013 - 03/2009
2	CollagenIBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	Ephrin-B2 (Ephrin B2)IBA 12/2017 - 12/2017
2	lysophosphatidic acidIBA 12/2016 - 01/2016
2	PAT-048IBA 12/2016 - 01/2016
2	Adenosine (Adenocard)FDA LinkGeneric 10/2011 - 03/2009
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2011 - 03/2009
1	Aurora Kinase AIBA 01/2022
1	4- (3- chloro- 2- fluorophenoxy)- 1- ((6- (1,3- thiazol- 2- ylamino)pyridin to 2-yl)methyl) cyclohexanecarboxylic acidIBA 01/2022
1	Aurora Kinase BIBA 01/2022
1	Netrin-1IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 01/2020
1	NIMA-Related KinasesIBA 01/2020
1	Mevalonic Acid (Mevalonate)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2018
1	rho-Associated KinasesIBA 01/2018
1	DisintegrinsIBA 12/2017
1	Metalloproteases (Metalloproteinases)IBA 12/2017
1	Warfarin (Coumadin)FDA LinkGeneric 05/2017
1	Dabigatran FDA Link 05/2017
1	Peptide Hydrolases (Proteases)FDA Link 05/2017
1	Thrombin FDA Link 05/2017
1	Hemostatics (Antihemorrhagics)IBA 05/2017
1	IntegrinsIBA 05/2017
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	LipidsIBA 12/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2016
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2016
1	Interferon Type IIBA 05/2013
1	Peptides (Polypeptides)IBA 10/2011
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2009
1	CytokinesIBA 03/2009
1	ChemokinesIBA 03/2009
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 11/2008
1	AntioxidantsIBA 11/2008
1	Flucytosine (Ancobon)FDA Link 01/2007
1	posaconazole FDA Link 01/2007
1	Fluconazole (Zonal)FDA LinkGeneric 01/2007
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2007

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2007
1	Enteral Nutrition (Feeding, Tube) 12/2022
1	Extracorporeal Membrane Oxygenation 12/2021
1	Pneumonectomy (Lung Volume Reduction) 01/2021
1	Denervation 01/2021